PREVALENCE OF HEPATITIS B, HEPATITIS C AND HIV IN MULTIPLY TRANSFUSED SICKLE CELL DISEASE PATIENTS FROM OMAN

Background: In Oman, the prevalence of hepatitis B (HBV) infection is 5.8% with 2.8–7.1% HBV carriers. Hepatitis C (HCV) prevalence amongst Omanis is 0.41%. A total of 2917 human immunodeficiency virus (HIV) infections were notified amongst Omanis by 2017. This study was performed as there was no da...

Full description

Saved in:
Bibliographic Details
Main Authors: Anil Pathare, Salam Alkindi, prof.
Format: Article
Language:English
Published: PAGEPress Publications 2019-10-01
Series:Mediterranean Journal of Hematology and Infectious Diseases
Subjects:
Online Access:http://mjhid.org/index.php/mjhid/article/view/4032
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1850032190097719296
author Anil Pathare
Salam Alkindi, prof.
author_facet Anil Pathare
Salam Alkindi, prof.
author_sort Anil Pathare
collection DOAJ
description Background: In Oman, the prevalence of hepatitis B (HBV) infection is 5.8% with 2.8–7.1% HBV carriers. Hepatitis C (HCV) prevalence amongst Omanis is 0.41%. A total of 2917 human immunodeficiency virus (HIV) infections were notified amongst Omanis by 2017. This study was performed as there was no data on the prevalence of HIV, HBV and HCV in sickle cell disease (SCD) patients from Oman.   Study Design and Methods: In this retrospective, cross-sectional study, medical records of all SCD patients who attended our hospital between 2011 to 2017 were retrieved from the hospital information system. Following approval by the local medical research and ethics committee, data on HIV, HBV and HCV exposure were recorded to estimate the prevalence.   Results: Amongst a total of 1000 SCD patients (491 males and 509 females), twenty-three (2.3%) patients showed positive serology for hepatitis B surface antigen (HbsAg), of whom sixteen (1.6%) were HBV DNA positive.  126 (12.6%) had anti-HCV antibodies (anti-HCV), of whom fifty-two (5.2%) were HCV RNA positive. None of the patients had positive serology for HIV. A normal liver was observed on abdominal ultrasound in 788 (78.8%) patients, whereas, 208 (20.8%) had hepatomegaly and 4 (0.4%) had liver cirrhosis. Thirty-six (3.6%) patients died, but in only two patients, the mortality was due to cirrhosis of the liver.   Conclusion: This study provides the first comprehensive data on the prevalence of HBV and HCV infections among Omani SCD patients exposed to blood transfusions. Reassuringly, no case with HIV was observed.   Keywords: Prevalence; Hepatitis; HBV; HCV; HIV; infection
format Article
id doaj-art-65c94de774ca46388f49fbac244a1ec1
institution DOAJ
issn 2035-3006
language English
publishDate 2019-10-01
publisher PAGEPress Publications
record_format Article
series Mediterranean Journal of Hematology and Infectious Diseases
spelling doaj-art-65c94de774ca46388f49fbac244a1ec12025-08-20T02:58:44ZengPAGEPress PublicationsMediterranean Journal of Hematology and Infectious Diseases2035-30062019-10-0111110.4084/mjhid.2019.058PREVALENCE OF HEPATITIS B, HEPATITIS C AND HIV IN MULTIPLY TRANSFUSED SICKLE CELL DISEASE PATIENTS FROM OMANAnil Pathare0Salam Alkindi, prof.1Sultan Qaboos UniversityProfessor in Haematology and Consultant Haematologist, Department of Haematology, College of Medicine & Health Sciences, Sultan Qaboos University, P. O. Box 35, Muscat 123,Background: In Oman, the prevalence of hepatitis B (HBV) infection is 5.8% with 2.8–7.1% HBV carriers. Hepatitis C (HCV) prevalence amongst Omanis is 0.41%. A total of 2917 human immunodeficiency virus (HIV) infections were notified amongst Omanis by 2017. This study was performed as there was no data on the prevalence of HIV, HBV and HCV in sickle cell disease (SCD) patients from Oman.   Study Design and Methods: In this retrospective, cross-sectional study, medical records of all SCD patients who attended our hospital between 2011 to 2017 were retrieved from the hospital information system. Following approval by the local medical research and ethics committee, data on HIV, HBV and HCV exposure were recorded to estimate the prevalence.   Results: Amongst a total of 1000 SCD patients (491 males and 509 females), twenty-three (2.3%) patients showed positive serology for hepatitis B surface antigen (HbsAg), of whom sixteen (1.6%) were HBV DNA positive.  126 (12.6%) had anti-HCV antibodies (anti-HCV), of whom fifty-two (5.2%) were HCV RNA positive. None of the patients had positive serology for HIV. A normal liver was observed on abdominal ultrasound in 788 (78.8%) patients, whereas, 208 (20.8%) had hepatomegaly and 4 (0.4%) had liver cirrhosis. Thirty-six (3.6%) patients died, but in only two patients, the mortality was due to cirrhosis of the liver.   Conclusion: This study provides the first comprehensive data on the prevalence of HBV and HCV infections among Omani SCD patients exposed to blood transfusions. Reassuringly, no case with HIV was observed.   Keywords: Prevalence; Hepatitis; HBV; HCV; HIV; infectionhttp://mjhid.org/index.php/mjhid/article/view/4032Prevalence; Hepatitis; HBV; HCV; HIV; infection
spellingShingle Anil Pathare
Salam Alkindi, prof.
PREVALENCE OF HEPATITIS B, HEPATITIS C AND HIV IN MULTIPLY TRANSFUSED SICKLE CELL DISEASE PATIENTS FROM OMAN
Mediterranean Journal of Hematology and Infectious Diseases
Prevalence; Hepatitis; HBV; HCV; HIV; infection
title PREVALENCE OF HEPATITIS B, HEPATITIS C AND HIV IN MULTIPLY TRANSFUSED SICKLE CELL DISEASE PATIENTS FROM OMAN
title_full PREVALENCE OF HEPATITIS B, HEPATITIS C AND HIV IN MULTIPLY TRANSFUSED SICKLE CELL DISEASE PATIENTS FROM OMAN
title_fullStr PREVALENCE OF HEPATITIS B, HEPATITIS C AND HIV IN MULTIPLY TRANSFUSED SICKLE CELL DISEASE PATIENTS FROM OMAN
title_full_unstemmed PREVALENCE OF HEPATITIS B, HEPATITIS C AND HIV IN MULTIPLY TRANSFUSED SICKLE CELL DISEASE PATIENTS FROM OMAN
title_short PREVALENCE OF HEPATITIS B, HEPATITIS C AND HIV IN MULTIPLY TRANSFUSED SICKLE CELL DISEASE PATIENTS FROM OMAN
title_sort prevalence of hepatitis b hepatitis c and hiv in multiply transfused sickle cell disease patients from oman
topic Prevalence; Hepatitis; HBV; HCV; HIV; infection
url http://mjhid.org/index.php/mjhid/article/view/4032
work_keys_str_mv AT anilpathare prevalenceofhepatitisbhepatitiscandhivinmultiplytransfusedsicklecelldiseasepatientsfromoman
AT salamalkindiprof prevalenceofhepatitisbhepatitiscandhivinmultiplytransfusedsicklecelldiseasepatientsfromoman